EpilepsyGTx
ScaleupBiotech & Life SciencesBritish
Gene-therapy spinout developing single-dose AAV gene therapy (lead programme EPY201) delivered locally to the seizure focus for focal refractory epilepsy.
Locations
London, United Kingdom (Headquarters)
Victoria House, Bloomsbury Square, London, Greater London, WC1B 4DA, United Kingdom
View on mapCanterbury, United Kingdom
Camburgh House, 27 New Dover Road, Canterbury, Kent, CT1 3DN, United Kingdom
View on map